ubt251 vs retatrutide Goodbye Retatrutide? Meet — Novo Nordisk's Triple G Answer Retatrutide vs Tirzepatide | FIRST
Description
Reassuringly, only a very small percentage of people with T2D experienced hypoglycaemia in the phase 2 trial which included people on lifestyle interventions or metformin
It demonstrated a 14% reduction in major cardiovascular events and a 26% reduction in heart attacks specifically for Asian patients.[19] The kidney story gained momentum with the FLOW trial, the first dedicated kidney outcomes study of a GLP-1 medicine
Sesti G, Avogaro A, Belcastro S, Bonora BM, Croci M, Daniele G, Dauriz M, Dotta F, Formichi C, Frontoni S, Invitti C, Orsi E, Picconi F, Resi V, Bonora E, Purrello F
On a GLP-1 medicine, protein is particularly important
